Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose chemotherapy and CD34+ autologous stem cell transplantation in progressive systemic sclerosis
2011-002434-40Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Aug 2011
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous cd34-selected peripheral blood stem cells in systemic sclerosis (SSc), sponsored by University Hospital Tübingen. Primary endpoint: Overall survival. Started Aug 2011; status: completed.
02
Drugs
autologous cd34-selected peripheral blood stem cells
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2011-002434-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002434-40.